Companies / Brazil
Mercosur's Medicines Policy Criticised
August 2006 | Industry NewsBrazilian health minister José Álvares da Silva has claimed that the medicines policy of South American trade bloc Mercosur is its 'Achilles heel'. The comments comes just months after the region's health officials pledged not to introduce so-called TRIPS-plus patent regulations, and promised to boost mutual co-operation on pharmaceutical pricing issues.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
